Related references
Note: Only part of the references are listed.Phase Ib study of BI 836880 (VEGF/Ang2 inhibitor) plus ezabenlimab (BI 754091; anti-PD-1 antibody) in patients (pts) with advanced hepatocellular carcinoma (HCC)
Tim Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
Masato et al.
SCIENTIFIC REPORTS (2022)
Overestimated renal function in patients with liver cirrhosis predicts poor prognosis
Sonoe Yoshida et al.
HEPATOLOGY RESEARCH (2022)
Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review
Catharina J. Alberts et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Recent advances in the treatment of hepatitis C virus infection for special populations and remaining problems
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
Yuki Tahata et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma
Taku Shigesawa et al.
PLOS ONE (2021)
Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C
Naoki Kawagishi et al.
SCIENTIFIC REPORTS (2021)
Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia
Sonoe Yoshida et al.
NUTRIENTS (2021)
High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C
Naoki Kawagishi et al.
HEPATOLOGY RESEARCH (2020)
Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people
Masatsugu Ohara et al.
HEPATOLOGY RESEARCH (2020)
Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma
Taku Shigesawa et al.
JGH OPEN (2020)
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis
Andrew S. Allegretti et al.
HEPATOLOGY (2019)
Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease
Sander Lefere et al.
HEPATOLOGY (2019)
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema BOULEVARD Phase 2 Randomized Trial
Jayashree Sahni et al.
OPHTHALMOLOGY (2019)
Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection
Takao Watanabe et al.
HEPATOLOGY RESEARCH (2019)
Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance
Norio Akuta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study
Juergen K. Rockstroh et al.
CLINICAL INFECTIOUS DISEASES (2018)
Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis
Rafael Esteban et al.
GASTROENTEROLOGY (2018)
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals
Francesca Faillaci et al.
HEPATOLOGY (2018)
Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C
Ezequiel Mauro et al.
HEPATOLOGY (2018)
Treatment of hepatitis C in special populations
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY (2018)
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2018)
Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients
Kosh Agarwal et al.
JOURNAL OF HEPATOLOGY (2018)
Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Tomokazu Souma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment
E. Ogawa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
Hiroko Nagata et al.
JOURNAL OF HEPATOLOGY (2017)
Therapeutic targeting of the angiopoietin-TIE pathway
Pipsa Saharinen et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Susanna Naggie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response
Yoshihiko Tachi et al.
HEPATOLOGY RESEARCH (2015)
Overexpression of angiopoietin-2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition
Montse Pauta et al.
LIVER INTERNATIONAL (2015)
Angiopoietin-2 Is Critical for Cytokine-Induced Vascular Leakage
Andrew V. Benest et al.
PLOS ONE (2013)
Flow-dependent regulation of angiopoietin-2
Winfried Goettsch et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
